|
Press Releases |
|
 |
|
Friday, March 21, 2025 |
|
中國生物製藥(1177.HK)公佈2024全年業績 |
中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司(「中國生物製藥」或「公司」,連同附屬公司統稱「集團」)(股票編號:1177)公布截至2024年12月31日止12個月之經審核財務業績。 more info >> |
|
Thursday, March 20, 2025 |
|
Sino Biopharm (1177.HK) Announces 2024 Annual Results |
Sino Biopharmaceutical Limited ('Sino Biopharm' or the 'Company', together with its subsidiaries, the 'Group') (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2024. more info >> |
|
Friday, March 21, 2025 |
|
中国生物制药(1177.HK)公布2024全年业绩 |
中国领先的创新研发驱动型医药集团—中国生物制药有限公司(「中国生物制药」或「公司」,连同附属公司统称「集团」)(股票编号:1177)公布截至2024年12月31日止12个月之经审核财务业绩。 more info >> |
|
Wednesday, August 14, 2024 |
|
中国生物制药(1177.HK)公布2024中期业绩 |
more info >> |
|
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results |
Sino Biopharmaceutical Limited (?Sino Biopharmaceutical? or the ?Company?, together with its subsidiaries, the ?Group?) (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2024 (the ?Period?). more info >> |
|
中國生物製藥(1177.HK)公佈2024中期業績 |
中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司(「中國生物製藥」或「公司」,連同附屬公司統稱「集團」)(股票編號:1177)公佈截至2024年6月30日止6個月(「期內」)之未經審核財務業績。 more info >> |
|
Monday, April 22, 2024 |
|
中国生物制药董事会主席及首席执行长近日连续增持公司股份合共750万股 |
中国生物制药(1177.HK)2024年年初至今多次回购公司股份的同时,董事会成员亦接连增持公司股份,集团董事会主席谢其润女士于4月19日增持250万股公司股份,集团执行董事及首席执行长谢承润先生亦增持500万股公司股份。 more info >> |
|
中國生物製藥董事會主席及首席執行長近日連續增持公司股份合共750萬股 |
中國生物製藥(1177.HK)2024年年初至今多次回購公司股份的同時,董事會成員亦接連增持公司股份,集團董事會主席謝其潤女士於4月19日增持250萬股公司股份,集團執行董事及首席執行長謝承潤先生亦增持500萬股公司股份。 more info >> |
|
Friday, March 29, 2024 |
|
中国生物制药(1177.HK)公布2023全年业绩 |
创新产品 继续丰收 收入达人民币262.0亿元 经调整非《香港财务报告准则》归母净利润达人民币25.9亿元 more info >> |
|
中國生物製藥(1177.HK)公布2023全年業績 |
more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Galaxy Payroll Group Limited Announces Execution of PIPE Financing Agreements
Jul 15, 2025 05:30 HKT/SGT
|
|
|
Kingnet Acquired Type 4 and Type 9 Licenses: Continuously Broadening Business Boundaries and Advancing Global Expansion Layout
Jul 14, 2025 23:47 HKT/SGT
|
|
|
愷英網絡獲得4號及9號牌照:持續拓寬業務邊界 全球化佈局更進一步
Jul 14, 2025 23:46 HKT/SGT
|
|
|
Graphene Aluminium Ion Battery Patent Granted and GMG and The University of Queensland Enter into New Collaboration Agreement
Jul 14, 2025 20:09 HKT/SGT
|
|
|
BlockBits Launches a Futures Trading Service, Offering Traders a Wide Range of Advanced Tools
Jul 14, 2025 20:00: JST
|
|
|
BlockBits Launches a Futures Trading Service, Offering Traders a Wide Range of Advanced Tools
Jul 14, 2025 20:00 HKT/SGT
|
|
|
XDS Datacentres signs 15-year deal to host 10MW of AI workloads in Saudi's Desert Dragons facilities
Jul 14, 2025 18:00: JST
|
|
|
XDS Datacentres signs 15-year deal to host 10MW of AI workloads in Saudi's Desert Dragons facilities
Jul 14, 2025 17:00 HKT/SGT
|
|
|
恺英网络获得4号及9号牌照:持续拓宽业务边界 全球化布局更进一步
Jul 14, 2025 16:01 HKT/SGT
|
|
|
Buy International Homes at the Global Property Expo, Singapore
Jul 14, 2025 14:48 HKT/SGT
|
|
|
富士通、特化型AIエージェントでグローバルサプライチェーンを最適化するソリューションが、ビジネスを変革する先進事例として選定
Jul 14, 2025 11:00: JST
|
|
|
Fujitsu's AI-powered supply chain solution selected as transformative example of applied-AI technology by World Economic Forum
Jul 14, 2025 10:30 JST
|
|
|
"URECE" (Dotinurad) Launched in China as a treatment for Gout
Jul 14, 2025 10:20 JST
|
|
|
エーザイ、痛風治療剤「URECE」(一般名:ドチヌラド)を中国において新発売
Jul 14, 2025 09:00: JST
|
|
|
Mitsubishi Motors Added to FTSE4Good Index Series, FTSE Blossom Japan Index and FTSE Blossom Japan Sector Relative Index for Consecutive Years
Jul 11, 2025 16:28 JST
|
|
|
|
More News >> |
|
|
|
|
|